Cargando…

Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral Therapy

BACKGROUND: Accurate, inexpensive point-of-care CD4+ T cell testing technologies are needed that can deliver CD4+ T cell results at lower level health centers or community outreach voluntary counseling and testing. We sought to evaluate a point-of-care CD4+ T cell counter, the Pima CD4 Test System,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manabe, Yukari C., Wang, Yaping, Elbireer, Ali, Auerbach, Brandon, Castelnuovo, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334961/ https://www.ncbi.nlm.nih.gov/pubmed/22536323 http://dx.doi.org/10.1371/journal.pone.0034319

Ejemplares similares

Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings
por: Kiragga, Agnes N, et al.
Publicado: (2010)

Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings
por: Castelnuovo, Barbara, et al.
Publicado: (2011)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
por: Sempa, Joseph, et al.
Publicado: (2012)

Prevalence of HIV-Associated Metabolic Abnormalities among Patients Taking First-Line Antiretroviral Therapy in Uganda
por: Omech, Bernard, et al.
Publicado: (2012)

Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda
por: Hermans, Sabine M, et al.
Publicado: (2017)

Point counter point : a novel /
por: Huxley, Aldous, 1894-1963
Publicado: (1955)

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
por: Reynolds, Steven J, et al.
Publicado: (2012)

Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy
por: Mahy, Mary, et al.
Publicado: (2010)

Among Patients with Sustained Viral Suppression in a Resource-Limited Setting, CD4 Gains Are Continuous Although Gender-Based Differences Occur
por: Sempa, Joseph B., et al.
Publicado: (2013)

Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility
por: Callens, Steven FJ, et al.
Publicado: (2008)

CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy
por: Peeling, Rosanna W., et al.
Publicado: (2015)

A Sensitive, Point-of-Care Detection of Small Molecules Based on a Portable Barometer: Aflatoxins In Agricultural Products
por: Zhang, Weiqi, et al.
Publicado: (2020)

Portable Tools for COVID-19 Point-of-Care Detection: A Review
Publicado: (2021)

CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm(3) Versus Universal Eligibility for Antiretroviral Therapy
por: Schooley, Alan L., et al.
Publicado: (2016)

Portable biosensors and point-of-care systems
por: Kintzios, Spyridon E, et al.
Publicado: (2017)

A portable immunosensor provides sensitive and rapid detection of Borrelia burgdorferi antigen in spiked blood
por: Kim, Sangsik, et al.
Publicado: (2023)

Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy
por: Page, I D, et al.
Publicado: (2013)

A Portable Microfluidic System for Point-of-Care Detection of Multiple Protein Biomarkers
por: Li, Nan, et al.
Publicado: (2021)

Reduction in Early Mortality on Antiretroviral Therapy for Adults in Rural South Africa Since Change in CD4(+) Cell Count Eligibility Criteria
por: Lessells, Richard J., et al.
Publicado: (2014)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Highly sensitive and portable mRNA detection platform for early cancer detection
por: Li, Hongxia, et al.
Publicado: (2021)

The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
por: Manabe, Yukari C.
Publicado: (2023)

Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland
por: Bock, Naomi N., et al.
Publicado: (2016)

Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients
por: Beer, Linda, et al.
Publicado: (2015)

Risk factors for mortality among malnourished HIV-infected adults eligible for antiretroviral therapy
por: Woodd, Susannah L, et al.
Publicado: (2016)

Point‐of‐care detection of Japanese encephalitis virus biomarker in clinical samples using a portable smartphone‐enabled electrochemical “Sensit” device
por: Roberts, Akanksha, et al.
Publicado: (2023)

Advances in Point-of-Care Testing of microRNAs Based on Portable Instruments and Visual Detection
por: Wang, Zhong-Yu, et al.
Publicado: (2023)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya
por: Odeny, Thomas A, et al.
Publicado: (2015)

Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa
por: McGrath, N, et al.
Publicado: (2015)

Portable and sensitive air pollution monitoring
por: Su, Judith
Publicado: (2018)

Performances of some low-cost counter electrode materials in CdS and CdSe quantum dot-sensitized solar cells
por: Jun, Hieng Kiat, et al.
Publicado: (2014)

A Sensitive and Portable Double-Layer Microfluidic Biochip for Harmful Algae Detection
por: Li, Ping, et al.
Publicado: (2022)

A Portable Droplet Magnetofluidic Device for Point-of-Care Detection of Multidrug-Resistant Candida auris
por: Lee, Pei-Wei, et al.
Publicado: (2022)

High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
por: Nakanjako, Damalie, et al.
Publicado: (2011)

Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda
por: Jaffar, Shabbar, et al.
Publicado: (2008)

Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis
por: Manabe, Yukari C., et al.
Publicado: (2012)

Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach
por: Tenforde, Mark W., et al.
Publicado: (2019)

Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on Antiretroviral Therapy (ART) in sub-Saharan Africa: Frequency and clinical significance
por: Nakanjako, Damalie, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_i2mqb9mkiuk5jhcdcpibcaj7m3